диссертации / 48
.pdf142.de Jong G., van Raak L., Kessels F., Lodder J. Stroke subtype and mortality. a follow-up study in 998 patients with a first cerebral infarct. J Clin Epidemiol. 2003;56:262–8.
143.Demirkaya S., Topcuoglu M.A., Aydin A. et al. Malonaldehyde, glutathione peroxidase and super oxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Eur. J. Neurol. 8:43– 51; 2001.
144.Di Carlo A., Lamassa M., Baldereschi M. et al. Risk factors and outcome of subtypes of ischemic stroke. Data from a multicenter multinational hospital-based registry. The European Community Stroke Project. J Neurol Sci. 2006;244(1-2):143-50.
145.Di Tullio M.R., Zwas D.R., Sacco R.L. et al. Left ventricular mass and geometry and the risk of ischemic stroke. Stroke. 2003; 34(10):2380-4.
146.Domanski M.J., Davis B.R., Pfeffer M.A. et al. Isolated systolic hypertension. Prognostic information provided by pulse pressure. Hypertension 1999; 34: 375–380.
147.Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet. 2008; 371(9624): 1612-1623.
148.El Kossi M.H., Zakhary M.M. Oxidative stress in the context of acute cerebrovascular stroke. Stroke 31:1889– 1892; 2000.
149.Elnakish M.T., Hassanain H.H., Janssen P.M. et al. Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase. J Pathol. 2013; 231(3): 290-300.
150.Ergul A., Elgebaly M.M., Middlemore M.L. et al. Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes. BMC Neurol. 2007; 7:33.
151.Espat N.J., Nelton W.S. Oxygen free radicals, oxidative stress, and antioxidants in critical illness. Support Line. – 2000. - 22:11–20
152.Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stressactivated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002;23:599–622.
153.Feigin V.L., Lawes C.M., Bennett D.A., Anderson C.S. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003; 2(1): 43-53.
154.Fischer U., Arnold M., Nedeltchev K. et al. NIHSS score and arteriographic findings in acute ischemic stroke. Stroke. 2005;36:2121–5.
155.Fong J.J., Rhoney D.H. NXY-059: review of neuroprotective potential for acute stroke. Ann. Pharmacother., 2006, 40(3):461-71.
151
156.Frenkel W.J., Jongerius E.J., Mandjes-van Uitert M.J. et al. Validation of the charlson comorbidity index in acutely hospitalized elderly adults: a prospective cohort study. J Am Geriatr Soc. 2014;62(2):342-6.
157.Frier B.M. Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited. Diabetologia. 2011; 54(2):233–6.
158.Fuster V., Ryden L., Cannom D., et al. American College of Cardiology, American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm Society: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 651–745.
159.Gentile N.T., Seftchick M.W., Huynh T. et al. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med. 2006;13:174–180.
160.Giaquinto S., Ferrara I., Muscherà R. et al. The effects of atrial fibrillation on functional recovery in post-stroke patients. Disabil Rehabil. 2001; 23(5): 204-208.
161.Gilgun-Sherki Y., Rosenbaum Z., Melamed E., Offen D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol. Rev. 2002, 54(2):271-84.
162.Giordano F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest. – 2005. -
115:500–508.
163.Goldberg D. The need for a special classification of mental disorders for general medical practice: towards ICD11 – Primary Care. European Psychiatry 2011: 26:53-56.
164.Grabska K., Niewada M., Sarzyńska-Długosz I. et al. Pulse pressure--independent predictor of poor early outcome and mortality following ischemic stroke. Cerebrovasc Dis. 2009; 27(2): 187-192.
165.Gruener N., Gross B., Gozlan O., Barak M. Increase in superoxide dismutase after cerebrovascular accident. Life Sci. 54:711–713; 1994.
166.Grumbach K. Chronic illness, comorbidities, and the need for medical generalism. Annals of Family medicine 2003; 1: 4-7.
167.Hack W., Kaste M., Bogousslavsky J., et al. European Stroke Initiative Recommendations for Stroke Management—update 2003. Cerebrovasc Dis. 2003; 16: 311–337.
168.Halliwell B. Biochemistry of oxidative stress // Biochemical Society Transactions. – 2007. - Vol.35(part 5). – Р. 1147-1150.
169.Halliwell B., Gutteridge J.М.С. Free Radicals in Biology and Medicine. 4th ed. - Oxford:
Oxford University Press. - 2007. – Р.851.
152
170.Henon H., Godefroy O., Leys D. et al. Early predictors of death and disability after acute cerebral ischemic event. Stroke. 1995;26:392–8.
171.Howard V.J. Reasons underlying racial differences in stroke incidence and mortality. Stroke. 2013;44(6 Suppl 1):126-128.
172.Hoxworth J.M., Xu K., Zhou Y. et al. Cerebral metabolic profile, selective neuron loss, and survival of acute and chronic hyperglycemic rats following cardiac arrest and resuscitation. Brain Res. 1999; 821: 467–479.
173.Jackson C., Sudlow C. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke. 2005; 36(4): 891-901.
174.Janghorbani M., Hu F.B., Willett W.C. et al. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses’ Health Study. Diabetes Care. 2007; 30(7):
1730–1735.
175.Jazra C., Khoury M. Atrial fibrillation and stroke: risk stratification and new anticoagulants. J Med Liban. 2013; 61(2): 109-112.
176.Kammersgaard L., Olsen T. Cardiovascular risk factors and 5-year mortality in the Copenhagen Stroke Study. Cerebrovasc Dis 2005; 21: 187–193.
177.Kannel W., Abbott R., Savage D., McNamara P. Epidemiologic features of chronic AF. The Framingham Study. N Engl J Med 1982; 306: 1018–1022.
178.Kasparova S., Brezova V., Valko M. et al. Study of the oxidative stress in a rat model of chronic brain hypoperfusion. Neurochem Int. – 2005. - 46:601–611
179.Kawai N., Keep R.F., Betz A.L. Effects of hyperglycemia on cerebral blood flow and edema formation after carotid artery occlusion in Fischer 344 rats. Acta Neurochir Suppl. 1997; 70: 34–36.
180.Keezer M.R., Yu A.Y., Zhu B. et al. Blood pressure and antihypertensive therapy as predictors of early outcome in acute ischemic stroke. Cerebrovasc Dis 2008; 25: 202–208.
181.Kelly-Hayes M., Wolf P.A., Kannel W.B. et al. Factors influencing survival and need for institutionalization following stroke: the Framingham Study. Arch Phys Med Rehabil. 1988; 69: 415 –418.
182.Kimura K., Iguchi Y., Yamashita S. et al. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke. J Neurol Sci 2008; 267: 57–
61.
183. Kimura K., Minematsu K., Yamaguchi T. Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke. J Neurol Neurosurg
Psychiatry. 2005; 76: 679–683.
153
184.Kinlay S. Changes in stroke epidemiology, prevention, and treatment. Circulation. 2011; 124(19): 494-496.
185.Kolominsky-Rabas P., Weber M., Gefeller O. et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001; 32: 2735–2740.
186.Krahn A., Manfreda J., Tate R. et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995: 98; 476–484.
187.Laing S.P., Swerdlow A.J., Carpenter L.M. et al. Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke. 2003; 34(2):418–421.
188.Landmesser U., Spiekermann S., Dikalov S. et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure. Role of xanthine oxidase and extracellular superoxide dismutase. Circulation. – 2002. - 106:3073–3078
189.Laurent S., Katsahian S., Fassot C. et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003; 34: 1203–1206.
190.Lees K.R., Zivin J.A., Ashwood T. et al. NXY-059 for acute ischemic stroke. N. Engl. J. Med., 2006, 354(6):588-600.
191.Leinonen J.S., Ahonen J.P., Lo¨ nnrot K. et al. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke. – 2000. - 31:33–39.
192.Leonardi-Bee J., Bath P.M., Phillips S.J., Sandercock P.A. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33: 1315–1320.
193.Li W., Prakash R., Kelly-Cobbs A.I. et al. Adaptive Cerebral Neovascularization in a Model of Type 2 Diabetes: Relevance to Focal Cerebral Ischemia. Diabetes. 2010; 59:228–235.
194.Liggins J.T., Yoo A.J., Mishra N.K. et al. A score based on age and DWI volume predicts poor outcome following endovascular treatment for acute ischemic stroke. Int J Stroke. 2013
195.Lin B., Ginsberg M.D., Busto R. Hyperglycemic exacerbation of neuronal damage following forebrain ischemia: microglial, astrocytic and endothelial alterations. Acta Neuropathol. 1998; 96: 610–620.
196.Lindsberg P.J., Roine R.O. Hyperglycemia in acute stroke. Stroke. 2004; 35(2): 363–364.
197.Loh K.P., Huang S.H., De Silva R. et al. Oxidative stress: apoptosis in neuronal injury. Curr. Alzheimer Res., 2006, 3(4): 327-337.
198.Love S. Oxidative stress in brain ischemia. Brain Pathol. 1999; 9(1): 119-131.
199.Mangiarua E.I., Lee R.M. Morphometric study of cerebral arteries from spontaneously hypertensive and stroke-prone spontaneously hypertensive rats. J Hypertens 1992; 10: 1183–
1190.
154
200.Manzanero S., Santro T., Arumugam T.V. Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury. Neurochem Int. 2013; 62(5): 712-718.
201.Miteff F., Levi C., Bateman G. et al. The independent predictive utility of CT angiographic collateral status in acute ischemic stroke. Brain 2009; 132: 2231–2238.
202.Miyasaka Y., Barnes M., Gersh B. et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119–125.
203.Moncayo J., Devuyst G., Van Melle G., Bogousslavsky J. Coexisting causes of ischemic stroke. Arch Neurol. 2000; 57(8): 1139-1144.
204.Morley J.E., Perry H.M., Miller D.K. Something about frailty. J Gerontol A Biol Sci Med Sci 2002;57: 698–704.
205.Nagata K., Suzuki K. Update on stroke epidemiology. Brain Nerve. 2013; 65(7): 857-
870.
206.Nedeltchev K., Renz N., Karameshev A. et al. Predictors of early mortality after acute ischaemic stroke. Swiss Med Wkly. 2010; 140(17-18): 254-259.
207.Newman E.J., Rahman F.S., Lees K.R. et al. Elevated serum urate concentration independently predicts poor outcome following stroke in patients with diabetes. Diabetes Metab Res Rev. 2006; 22: 79–82.
208.Ntaios G., Egli M., Faouzi M., Michel P. J–shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke. 2010; 41(10):2366–2370.
209.Paciaroni M., Agnelli G., Caso V. et al. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis 2009; 28: 119–123.
210.Paciaroni M., Agnelli G., Corea F. et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 2008; 39: 2249– 2256.
211.Paciaroni M., Bogousslavsky J. Primary and secondary prevention of ischemic stroke. Eur Neurol. 2010;63(5):267-278.
212.Parsons M.W., Barber P.A., Desmond P.M. et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002; 52: 20–28.
213.Patton N., Aslam T., Macgillivray T. et al. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat. 2005; 206(4): 319–348.
214.Paultre F., Mosca L. Association of blood pressure indices and stroke mortality in
isolated systolic hypertension. Stroke 2005; 36: 1288–1290.
155
215.Paulus W.J., Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4): 263-271.
216.Podolecki T.S., Lenarczyk R., Kowalczyk J. et al. The incidence and risk factors of stroke in patients with acute myocardial infarction treated invasively and concomitant impaired renal function. Cardiol J. 2013
217.Polidori M.C., Frei B., Cherubini A. et al. Increased plasma levels of lipid hydroperoxydes in patients with ischemic stroke. Free Radic. Biol. Med. 1998; 25:561– 567.
218.Potashkin J.A., Meredith G.E. The role of oxidative stress in the dysregulation of gene expression and protein metabolism in neurodegenerative disease. Antioxid. Redox. Signal., 2006, 8(1-2):144-151.
219.Prencipe M., Culasso F., Rasura M. et al. Long-term prognosis after a minor stroke. 10year mortality and mayor stroke recurrence rates in a hospital-based cohort. Stroke 1998; 29: 126–132.
220.Pulsinelli W.A., Waldman S., Rawlinson D., Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology. 1982; 32: 1239–1246.
221.Ranta A. Transient ischaemic attack and stroke risk: pilot of a primary care electronic decision support tool. J Prim Health Care. 2013; 5(2): 138-140.
222.Rodrigo R., Fernández-Gajardo R., Gutiérrez R. et al. Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets. 2013; 12(5): 698-714.
223.Rothwell P.M., Warlow C.P. Timing of TIAs preceding stroke: time window for prevention is very short. Neurology. 2005; 64(5): 817-820.
224.Sacco R.L., Wolf P.A., Kannel W.B., McNamara P.M. Survival and recurrence following stroke. The Framingham Study. Stroke 1982;13:290–295.
225.Safar M.E., Levy B.I., Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107: 2864–2869.
226.Safar M.E. Peripheral pulse pressure, large arteries, and microvessels. Hypertension 2004; 44: 121–122.
227.Sarraj A., Albright K., Barreto A.D. et al. Optimizing prediction scores for poor outcome after intra-arterial therapy in anterior circulation acute ischemic stroke. Stroke. 2013; 44(12): 3324-3330.
228.Schmidt M., Jacobsen J.B., Johnsen S.P. et al. Eighteen-year trends in stroke mortality and the prognostic influence of comorbidity. Neurology. 2014; 82(4): 340-350.
156
229.Schulz U.G., Rothwell P.M. Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. // Stroke. – 2003. –
№34(8). – Р. 2050-2059.
230.SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) // JAMA. – 1991. – №265. – Р. 3255–3264.
231.Simonyi A., Wang Q., Miller R.L. et al. Polyphenols in cerebral ischemia: novel targets for neuroprotection // Mol. Neurobiol. – 2005. – №31(1-3). – Р.135-147.
232.Snozzi P., Blank P.R., Szucs T.D. Stroke in Switzerland: Social Determinants of Treatment Access and Cost of Illness. // J Stroke Cerebrovasc Dis. 2013
233.Spranger M., Krempien S., Schwab S. et al. Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury. Correlation with clinical course and infarct size // Stroke. – 1997. – №28. – Р. 2425– 2428.
234.Stead L.G., Gilmore R.M., Bellolio M.F. et al. Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke // Neurocrit Care. – 2009. – №10(2). – Р. 181-186.
235.Stead L.G., Gilmore R.M., Decker W.W. et al. Initial emergency department blood pressure as predictor of survival after acute ischemic stroke // Neurology. – 2005. – №65. –
Р.1179–1183.
236.Stiles M.C., Seaquist E.R. Cerebral structural and functional changes in type 1 diabetes // Minerva Med. – 2010. – №101(2). – Р.105–114.
237.Stollberger C., Exner I., Finsterer J. et al. Stroke in diabetic and non-diabetic patients: course and prognostic value of admission serum glucose // Ann Med. – 2005. – №37. – Р.357–
364.
238.Strand T., Marklund S.L. Release of superoxide dismutase into cerebrospinal fluid as a marker of brain lesion in acute cerebral infarction // Stroke. – 1992. - №23. – Р.515–518.
239.Strunets A., Mirza M., Sra J., Jahangir A. Novel anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly. // Expert Rev Clin Pharmacol. – 2013. – №6(6). – Р. 677-689.
240.Sundquist K., Li X. Type 1 diabetes as a risk factor for stroke in men and women aged 15–49: a nationwide study from Sweden // Diabet Med. – 2006. - №23(11). – Р.1261–1267.
241.Sweeney M.I., Yager J.Y., Walz W., Juurlink B.H. Cellular mechanisms involved in brain ischemia // Can. J. Physiol. Pharmacol. – 1995. – №73(11). – Р. 1525-1535.
242.Taylor A.W., Price K., Gill T.K. et al. Multimorbidity – not just an older person’s issue.
Result from an Australian biomedical study // BMC Public Health. – 2010. – №10. – Р.718.
157
243.Teale E.A., Munyombwe T.M., Young J.B. Scaling properties of the subjective index of physical and social outcome after stroke in a study population unselected by age. // Arch Phys Med Rehabil. – 2013. – №94(12). – Р.2448-2455.
244.The global burden of disease: 2004 update. Geneva, World Health Organization, 2008.
245.Thomalla G.J., Kucinski T., Schoder V. et al. Prediction of malignant middle cerebral artery infarction by early perfusionand diffusion-weighted magnetic resonance imaging // Stroke. – 2003. – №34. – Р.1892–1899.
246.Tomassoni D., Bellagamba G., Postacchini D. et al. Cerebrovascular and brain microanatomy in spontaneously hypertensive rats with streptozotocin-induced diabetes // Clin Exp Hypertens. – 2004. - №26(4). – Р. 305–321.
247.Tsivgoulis G., Spengos K., Zakopoulos N. et al. Twenty-four-hour pulse pressure predicts long-term recurrence in acute stroke patients // J Neurol Neurosurg Psychiatry. – 2005. - №76. –
Р. 1360–1365.
248.Valderas J.M., Starfield B., Sibbald B. et al. Defining comorbidity: Implications for understanding health and health services// Ann Fam Med. – 2009. - №7. – Р.357-363.
249.Van Bortel LMAB, Struijker-Boudier HAJ, Safar M.E. Pulse pressure, arterial stiffness and drug treatment of hypertension // Hypertension. – 2001. - №38. – Р.914–921.
250.Vemmos K.N., Tsivgoulis G., Spengos K. et al. Pulse pressure in acute stroke is an independent predictor of longterm mortality // Cerebrovasc Dis. – 2004. – №18. – Р.30–36.
251.Wahlgren N., Ahmed N., Eriksson N. et al., for the SITSMOST Investigators: Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomised controlled trials: SITSMOST // Stroke. – 2008. – №39. – Р.3316–
3322.
252. Wang C., Ko H.S., Thomas B et al. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function // Hum. Mol. Genet. – 2005. - №14(24). – Р. 3885-3897.
253.Wang L.Y., Xu J., Wang Y.L. et al. Effects of poststroke hypertension and hyperglycemia on functional outcomes in stroke patients without history of hypertension or diabetes. // CNS Neurosci Ther. – 2012. - №18(11). – Р.942-944.
254.Wang Q., Tompkins K.D., Simonyi A. et al. Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res. –
2006. - №1090(1). – Р.182-189.
255. Wang Y., Lim L.L., Levi C. et al. A prognostic index for 30-day mortality after stroke // J Clin Epidemiol. – 2001. - №54. – Р. 766–773.
158
256. Weimar C., Konig I.R., Kraywinkel K. et al. Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models // Stroke. – 2004. – №35. – Р. 158– 162.
257.Weinberger J.M. Evolving therapeutic approaches to treating acute ischemic stroke // J. Neurol. Sci. – 2006. – №249(2). – Р.101-109.
258.Weitzman D., Goldbourt U. The significance of various blood pressure indices for longterm stroke, coronary heart disease and all cause mortality in men. The Israeli Ischemic Heart Disease Study // Stroke. – 2006. – 37. – Р.358– 363.
259.Wikipedia, the free encyclopedia: Comorbidity, 1-14. http://en.wikipedia.org/wiki/Comorbidity
260.Williams L.S., Rotich J., Qi R. et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke // Neurology. – 2002. – 59. – Р.67–71.
261.Wolff J.L., Starfield B., Anderson G. Prevalence, expenditures, and complicationsof multiple chronic conditions in elderly // Arch Intern Med. – 2002. – №162. – Р. 2269-2276.
262.Wong A.A., Davis J.P., Schluter P.J. et al. The time course and determinants of blood pressure within the first 48 h after ischemic stroke // Cerebrovasc Dis. – 2007. – №24. – Р.426–
433.
263.World Health Report 2002. Reducing risks, promoting healthy life. Geneva, World Health Organization, 2002.
264.Yoshida H., Yanai H., Namiki Y. et al. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury // CNS. Drug Rev. – 2006. – №12(1). – Р.9-20.
265.Zeevalk G.D., Bernard L.P., Song C. et al. Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration // Antioxid. Redox. Signal. – 2005. – №7(9-10). – Р. 1117-1139.
266.Zoppini G., Verlato G., Zamboni C. et al. Pulse pressure and mortality from cerebrovascular diseases in type 2 diabetic patients: The Verona Diabetes Study // Cerebrovasc Dis. – 2007. – №23. – Р.20–26.
267.Zuliani G., Cherubini A., Ranzini M. et al. Risk factors for short-term mortality in older subjects with acute ischemic stroke // Gerontology. – 2006. –№52. – Р.231–236.
159